(Circulation. 1999;100:855-860.)
© 1999 American Heart Association, Inc.
Basic Science Reports |
Aggregating Human Platelets Stimulate Expression of Vascular Endothelial Growth Factor in Cultured Vascular Smooth Muscle Cells Through a Synergistic Effect of Transforming Growth Factor-ß1 and Platelet-Derived Growth FactorAB
From Institut für Kardiovaskuläre Physiologie, Klinikum der JWG-Universität (N.K., A.B., R.B., V.B.S.-K.), Frankfurt am Main and Fachbereich Hämostaseologie, Stiftung Deutsche Klinik für Diagnostik GmbH (S.B., C.M.K.), Wiesbaden, Germany.
Correspondence to V.B. Schini-Kerth, PhD, Institut für Kardiovaskuläre Physiologie, Klinikum der JWG-Universität, Theodor-Stern-Kai-7, D-60590 Frankfurt am Main, Germany. E-mail Schini-Kerth{at}em.uni-frankfurt.de
Background—Vascular endothelial growth factor (VEGF), an endothelial mitogen and chemoattractant, has been implicated in the recovery of the endothelium after balloon injury. The increased expression of VEGF in vascular smooth muscle cells (SMC) at sites of injury suggests that this cell type may be a major cellular source of VEGF. This study examined whether aggregating platelets stimulate VEGF expression in cultured SMC.
Methods and Results—VEGF expression in SMC was assessed by Northern blot analysis and by reverse transcription followed by polymerase chain reaction and the release of VEGF by Western blot analysis and immunoassay. Platelet-derived products (PDP) released by aggregating human platelets time-dependently and concentration-dependently enhanced VEGF mRNA levels, mainly that coding for the soluble splice variant VEGF165/164, and stimulated the release of VEGF protein. These effects were potentiated by transient acidification of PDP, which release bioactive transforming growth factor (TGF)-ß1, and mimicked by platelet-derived growth factor (PDGF)AB and TGF-ß1 in a synergistic manner. Both a TGF-ß–neutralizing antibody and a PDGF-neutralizing antibody significantly attenuated the effect of acidified PDP on VEGF production.
Conclusions—Aggregating human platelets induce VEGF mRNA expression in cultured SMC and the subsequent release of VEGF protein. This effect can be attributed to a supra-additive action of PDGFAB and TGF-ß1 and may represent a novel mechanism by which platelets contribute to the recovery of the endothelial lining at sites of balloon-injured arteries.
Key Words: platelet-derived factors • angiogenesis • muscle, smooth • arteriosclerosis
This article has been cited by other articles:
 |
|
 |
|
  X. Deng, S. Szabo, T. Khomenko, M. R. Jadus, and M. Yoshida Gene Therapy with Adenoviral Plasmids or Naked DNA of Vascular Endothelial Growth Factor and Platelet-Derived Growth Factor Accelerates Healing of Duodenal Ulcer in Rats J. Pharmacol. Exp. Ther., December 1, 2004; 311(3): 982 - 988. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Gawaz Role of platelets in coronary thrombosis and reperfusion of ischemic myocardium Cardiovasc Res, February 15, 2004; 61(3): 498 - 511. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M.-H. Oak, M. Chataigneau, T. Keravis, T. Chataigneau, A. Beretz, R. Andriantsitohaina, J.-C. Stoclet, S.-J. Chang, and V. B. Schini-Kerth Red Wine Polyphenolic Compounds Inhibit Vascular Endothelial Growth Factor Expression in Vascular Smooth Muscle Cells by Preventing the Activation of the p38 Mitogen-Activated Protein Kinase Pathway Arterioscler Thromb Vasc Biol, June 1, 2003; 23(6): 1001 - 1007. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. F. Dvorak Vascular Permeability Factor/Vascular Endothelial Growth Factor: A Critical Cytokine in Tumor Angiogenesis and a Potential Target for Diagnosis and Therapy J. Clin. Oncol., November 1, 2002; 20(21): 4368 - 4380. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Iba, H. Matsubara, Y. Nozawa, S. Fujiyama, K. Amano, Y. Mori, H. Kojima, and T. Iwasaka Angiogenesis by Implantation of Peripheral Blood Mononuclear Cells and Platelets Into Ischemic Limbs Circulation, October 8, 2002; 106(15): 2019 - 2025. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. P. Bracamonte, K. S. Rud, W. G. Owen, and V. M. Miller Ovariectomy increases mitogens and platelet-induced proliferation of arterial smooth muscle Am J Physiol Heart Circ Physiol, September 1, 2002; 283(3): H853 - H860. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. C. G. LEE, D. MELKERNEKER, P. J. THOMPSON, R. W. LIGHT, and K. B. LANE Transforming Growth Factor beta Induces Vascular Endothelial Growth Factor Elaboration from Pleural Mesothelial Cells in Vivo and in Vitro Am. J. Respir. Crit. Care Med., January 1, 2002; 165(1): 88 - 94. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Bassus, O. Herkert, N. Kronemann, A. Gorlach, D. Bremerich, C. M. Kirchmaier, R. Busse, and V. B. Schini-Kerth Thrombin Causes Vascular Endothelial Growth Factor Expression in Vascular Smooth Muscle Cells: Role of Reactive Oxygen Species Arterioscler Thromb Vasc Biol, September 1, 2001; 21(9): 1550 - 1555. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Bouloumie, C. Sengenes, G. Portolan, J. Galitzky, and M. Lafontan Adipocyte Produces Matrix Metalloproteinases 2 and 9: Involvement in Adipose Differentiation Diabetes, September 1, 2001; 50(9): 2080 - 2086. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. G. Christen, R. J. Glynn, U. A. Ajani, D. A. Schaumberg, E. Y. Chew, J. E. Buring, J. E. Manson, and C. H. Hennekens Age-Related Maculopathy in a Randomized Trial of Low-Dose Aspirin Among US Physicians Arch Ophthalmol, August 1, 2001; 119(8): 1143 - 1149. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Gorlach, I. Diebold, V. B. Schini-Kerth, U. Berchner-Pfannschmidt, U. Roth, R. P. Brandes, T. Kietzmann, and R. Busse Thrombin Activates the Hypoxia-Inducible Factor-1 Signaling Pathway in Vascular Smooth Muscle Cells : Role of the p22phox-Containing NADPH Oxidase Circ. Res., July 6, 2001; 89(1): 47 - 54. [Abstract] [Full Text] [PDF]
|
|